Loomis Sayles & Co. L P Makes New Investment in Amrize Ltd $AMRZ

Loomis Sayles & Co. L P purchased a new stake in Amrize Ltd (NYSE:AMRZFree Report) in the 2nd quarter, Holdings Channel.com reports. The institutional investor purchased 175,089 shares of the company’s stock, valued at approximately $8,676,000.

A number of other hedge funds have also modified their holdings of AMRZ. Allspring Global Investments Holdings LLC bought a new stake in Amrize during the second quarter worth about $62,646,000. Credit Industriel ET Commercial acquired a new position in shares of Amrize in the second quarter valued at about $109,000. TD Asset Management Inc bought a new position in shares of Amrize during the second quarter worth approximately $8,190,000. Generali Asset Management SPA SGR bought a new position in Amrize during the 2nd quarter worth $4,923,000. Finally, Allianz Asset Management GmbH acquired a new position in Amrize in the second quarter valued at about $158,530,000.

Insiders Place Their Bets

In related news, CTO Roald Brouwer purchased 4,000 shares of Amrize stock in a transaction dated Friday, October 31st. The stock was purchased at an average cost of $51.77 per share, for a total transaction of $207,080.00. Following the completion of the purchase, the chief technology officer directly owned 9,000 shares of the company’s stock, valued at $465,930. The trade was a 80.00% increase in their position. The purchase was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, CEO Jan Philipp Jenisch purchased 55,000 shares of the business’s stock in a transaction on Thursday, October 30th. The shares were purchased at an average price of $52.64 per share, with a total value of $2,895,200.00. Following the completion of the purchase, the chief executive officer owned 1,505,000 shares in the company, valued at approximately $79,223,200. This trade represents a 3.79% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Insiders acquired a total of 65,000 shares of company stock worth $3,399,720 in the last 90 days.

Wall Street Analyst Weigh In

Several brokerages have commented on AMRZ. JPMorgan Chase & Co. increased their target price on shares of Amrize from $52.00 to $60.00 and gave the stock an “overweight” rating in a report on Tuesday, August 26th. Wells Fargo & Company lifted their target price on shares of Amrize from $57.00 to $58.00 and gave the stock an “overweight” rating in a research note on Thursday, October 30th. Citigroup upped their price objective on shares of Amrize from $60.00 to $63.00 and gave the company a “buy” rating in a report on Monday, November 3rd. Vertical Research started coverage on shares of Amrize in a research report on Tuesday, November 25th. They issued a “hold” rating and a $54.00 price target on the stock. Finally, Wall Street Zen upgraded Amrize to a “hold” rating in a research note on Saturday, October 25th. One research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating and six have assigned a Hold rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $58.33.

Check Out Our Latest Report on Amrize

Amrize Price Performance

AMRZ opened at $52.02 on Tuesday. The company has a current ratio of 1.38, a quick ratio of 0.85 and a debt-to-equity ratio of 0.42. The stock’s 50 day moving average is $49.19. The company has a market cap of $28.77 billion and a price-to-earnings ratio of 28.27. Amrize Ltd has a 1 year low of $44.12 and a 1 year high of $56.29.

Amrize (NYSE:AMRZGet Free Report) last announced its quarterly earnings results on Wednesday, October 29th. The company reported $0.98 EPS for the quarter, missing analysts’ consensus estimates of $1.01 by ($0.03). The company had revenue of $3.68 billion during the quarter, compared to the consensus estimate of $3.49 billion. The firm’s revenue for the quarter was up 6.6% on a year-over-year basis.

Amrize Company Profile

(Free Report)

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.

Recommended Stories

Want to see what other hedge funds are holding AMRZ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amrize Ltd (NYSE:AMRZFree Report).

Institutional Ownership by Quarter for Amrize (NYSE:AMRZ)

Receive News & Ratings for Amrize Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amrize and related companies with MarketBeat.com's FREE daily email newsletter.